Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Cote

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|August 21, 2003
Occult metastases: real harm or false alarm?Richard J Cote
Urology|February 16, 2010
Editorial commentMarc Birkhahn, Richard J Cote
Urologic Oncology|July 14, 2007
Searching for novel therapeutics and targets: insights from clinical trialsAnirban P Mitra, Richard J Cote
Annual Review of Pathology|October 9, 2008
Molecular pathogenesis and diagnostics of bladder cancerAnirban P Mitra, Richard J Cote
Critical Reviews in Oncology/Hematology|July 10, 2003
Therapeutic approaches to bladder cancer: identifying targets and mechanismsRichard J Cote, Ram H Datar
Expert Review of Anticancer Therapy|June 29, 2011
Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales?Anirban P Mitra, Richard J Cote
Clinical Chemistry|May 12, 2011
Counterpoint: Both immunohistochemistry and fluorescence in situ hybridization play important roles for HER2 evaluationKenneth J Bloom, Richard J Cote
Nature Reviews. Urology|January 12, 2010
Molecular screening for bladder cancer: progress and potentialAnirban P Mitra, Richard J Cote
Frontiers in Oncology|June 9, 2015
Editorial: Prostate Cancer: What We Know and What We Would Like to KnowGianluigi Taverna, Richard J Cote, Fabio Grizzi
Expert Review of Anticancer Therapy|November 30, 2010
Expression profiling for bladder cancer: strategies to uncover prognostic factorsGeorg Bartsch, Anirban P Mitra, Richard J Cote
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Thoracic and Cardiovascular Surgery|August 21, 2003
Occult metastases: real harm or false alarm?Richard J Cote
Urology|February 16, 2010
Editorial commentMarc Birkhahn, Richard J Cote
Urologic Oncology|July 14, 2007
Searching for novel therapeutics and targets: insights from clinical trialsAnirban P Mitra, Richard J Cote
Annual Review of Pathology|October 9, 2008
Molecular pathogenesis and diagnostics of bladder cancerAnirban P Mitra, Richard J Cote
Critical Reviews in Oncology/Hematology|July 10, 2003
Therapeutic approaches to bladder cancer: identifying targets and mechanismsRichard J Cote, Ram H Datar
Expert Review of Anticancer Therapy|June 29, 2011
Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales?Anirban P Mitra, Richard J Cote
Clinical Chemistry|May 12, 2011
Counterpoint: Both immunohistochemistry and fluorescence in situ hybridization play important roles for HER2 evaluationKenneth J Bloom, Richard J Cote
Nature Reviews. Urology|January 12, 2010
Molecular screening for bladder cancer: progress and potentialAnirban P Mitra, Richard J Cote
Frontiers in Oncology|June 9, 2015
Editorial: Prostate Cancer: What We Know and What We Would Like to KnowGianluigi Taverna, Richard J Cote, Fabio Grizzi
Expert Review of Anticancer Therapy|November 30, 2010
Expression profiling for bladder cancer: strategies to uncover prognostic factorsGeorg Bartsch, Anirban P Mitra, Richard J Cote
Pageof 12